Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome

NCT06738732 is registered in ClinicalTrials.gov with Alexander Rotenberg as lead sponsor.

NCT NCT06738732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06738732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome
Lead sponsor
Alexander Rotenberg
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
January 31, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome (ds), lennox-gastaut syndrome (lgs)